News

MediPharm Labs Unveils Revolutionary Nighttime Inhaler Product

MediPharm Labs Unveils Revolutionary Nighttime Inhaler Product

MediPharm Labs Launches Innovative Nighttime Inhaler

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) has recently introduced an exciting product to its impressive CBN oil portfolio. The company, renowned for its advancements in precision-based cannabinoids, has unveiled the Shake & Puff CBN THC Nighttime Inhaler, offering a cutting-edge solution for nighttime use.

This new inhaler is designed to deliver a precise formulation of CBN and THC without the need for combustion or vapour. Consumers and medical patients can now enjoy a discreet and convenient way to experience the benefits of cannabinoids when they need them most.

Key Features of the New Nighttime Inhaler

The Shake & Puff inhaler is packed with remarkable benefits that set it apart from traditional cannabinoid delivery methods. Firstly, its metered dose format ensures accurate dosing with every use, allowing users to achieve consistent outcomes tailored to their needs. This precision is crucial, especially for consumers seeking controlled experiences.

Moreover, the inhaler provides a smoke-free and vapour-free option, allowing for a fast onset experience that many medical users favor. Its familiar design is similar to asthma inhalers, offering comfort and simplicity while being portable and discreet. Users can enjoy the inhaler without the concern of lingering odors or by-products.

One of the standout advantages of this delivery system is its direct-to-lung mechanism, which enhances the bioavailability of both CBN and THC compared to traditional edible formats. This means that users can experience faster effects, making it an optimal choice for those seeking quick relief when needed.

Future Prospects for MediPharm Labs

MediPharm Labs is not resting on its laurels with the launch of this impressive inhaler. The company plans to expand its lineup by introducing additional cannabinoid options, including CBD and CBG inhalers in the near future. This strategic direction aligns with the growing demand for innovative, pharma-grade cannabinoid products across regulated markets globally.

Furthermore, MediPharm Labs continues to evolve its offerings to meet the diverse needs of consumers. Alongside the inhaler, the company provides a variety of products such as tinctures, soft chews, and soft gels, allowing users to select the best method of consumption based on their preferences.

About MediPharm Labs

MediPharm Labs has built a reputation as a leader in the development and manufacture of purified cannabis concentrates and advanced cannabinoid products. Operating from a GMP-certified facility with ISO-grade clean rooms, the company prioritizes quality and safety to deliver trusted, precision-dosed products to its customers.

The company has made significant strides in the regulatory landscape, holding a Pharmaceutical Drug Establishment License from Health Canada. This achievement marks the company as a significant player in the North American medical cannabis domain.

In recent developments, MediPharm Labs acquired VIVO Cannabis Inc., broadening its reach to medical patients through enhanced platforms like Canna Farms medical e-commerce. This strategic move has facilitated better access to cannabis education and prescriptions across Canada, Australia, and Germany.

As MediPharm Labs charts its path forward, it remains committed to compliance with all legal and regulatory requirements in every market it serves.

Frequently Asked Questions

What is the Shake & Puff CBN THC Nighttime Inhaler?

The Shake & Puff Nighttime Inhaler is a smoke-free device designed to deliver precise doses of CBN and THC for nighttime use, ensuring quick relief and convenience.

How does the inhaler work?

This metered dose inhaler provides an accurate delivery system that allows users to inhale the cannabinoids directly into their lungs for increased bioavailability and rapid onset effects.

Can anyone use the nighttime inhaler?

While the inhaler is suitable for many consumers and medical patients, it's important to consult with a healthcare professional to determine if it's the right option for individual needs.

What other products does MediPharm Labs offer?

The company offers a diverse range of cannabinoid products, including tinctures, soft chews, and gels, catering to different preferences and therapeutic needs.

Where can I purchase the nighttime inhaler?

The inhaler is available at select Ontario retailers and through the Canna Farms medical platform, with plans for further expansions across Canada.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 150

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 136

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 176

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 128

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 161

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 191

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 154

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 187

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 175

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 261

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading

Top 5 Most Recently Viewed Articles

Important Updates for KinderCare Learning Investors Ahead of Deadline

Updated Category News Views 178

Urgent Notice for KinderCare Learning Companies, Inc. Investors Investors of KinderCare Learning Companies, Inc. (NYSE: KLC) should be aware of an essential deadline approaching shortly. Rosen Law Firm, a prominent name in investor rights law, is urging shareholders to take action as we approach an important date in the ongoing securities class action lawsuit. Why This...

Continue Reading
Exploring Current Trading Trends and Insights on Sea Ltd

Updated Category News Views 320

Understanding the Options Trading Activity for Sea Ltd In recent times, there has been notable bullish positioning by investors concerning Sea Ltd (NYSE: SE). Retail traders should certainly pay attention to these movements. Significant trading activity often indicates that investors may possess undisclosed insights or information related to the company's performance....

Continue Reading
Cornish Metals Expands Share Capital with New Stock Options

Updated Category News Views 214

Cornish Metals Strengthens Its Financial Position Vancouver-based Cornish Metals Inc. (TSX-V: CUSN, LSE: CUSN) is excited to announce a significant move to bolster its financial stature. The company, known for its focus on mineral exploration and development, specifically its permitted South Crofty tin project, has exercised stock options resulting in the issuance of...

Continue Reading
PRA Group Outlines Investor Conferences for Late 2024

Updated Category News Views 94

PRA Group to Showcase at Upcoming Investor Conferences PRA Group, Inc. (Nasdaq: PRAA), known for its expertise in acquiring and collecting nonperforming loans, has announced its lineup for several significant investor conferences in the coming months. This is an exciting opportunity for attendees to gain insights into the company's strategies and performance. Details on...

Continue Reading
Latino Parents Face Financial Strain, Seek AI Help

Updated Category News Views 103

Feeling the Heat: Latino Parents in U.S. Grappling With Rising Costs If you've ever wondered how families can keep floating in this economic sea, take a look at the Latino community in the U.S., particularly those with children. The latest BMO Real Financial Progress Index unpacks a story of strain, adaptation, and a surprising technology push. Parental Challenges: The...

Continue Reading